New Saturn-1 data demonstrated a strong patient responder rate with 95% of Demodex blepharitis patients treated with TP-03 achieving ≤0.5...
NOVA LIMA, MINAS GERAIS, Brazil, July 23, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that...
Clinical Study Confirms Quantitative Systems Pharmacology (QSP) Prediction, Showcasing the Power of Biosimulation TechnologyPRINCETON, N.J., July 23, 2021 (GLOBE NEWSWIRE)...
Virtual Pharmacy Made Easy; MyEasyDose Virtual Pharmacy Made Easy; MyEasyDose Virtual Pharmacy Made Easy; MyEasyDose Windsor, Ontario, July 23, 2021...
RALLY Study Will Stop Enrolling New Participants Following Recommendation from an Interim Analysis Indicating Inadequate Separation from Placebo at Week-14...
EDISON, N.J., July 23, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on the...
BROOKLYN, N.Y., July 23, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on...
CAMBRIDGE, Mass., July 23, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced it will share multiple oral and...
SAN JUAN CAPISTRANO, Calif., July 23, 2021 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group...
Featured Image Featured Image Featured Image 2 Featured Image 2 Initial Appointments Include Recognized Experts: Corey Anderson, MD; W. Paul...
